quarta-feira, 7 de outubro de 2026
PesquisarExplore
pt.VIA.NEWS
Source trace. Via News points to the documents behind its reporting and shows what we drew from each — so you can check any claim. How we source
Source document· April 2, 2026

Mizuho resets view on Snowflake stock after CRO change

View original at finance.yahoo.com
Mizuho resets view on Snowflake stock after CRO change Snowflake (SNOW) stock is starting to look interesting again. Shares are down about 30% this year while the company has just appointed a new chief revenue officer as it tries to reaccelerate growth and improve sales execution…
Opening lines of the source · short snapshot — read the full document at the original

O que extraímos desta fonte

The claims Via News extracted from this document. We point to the source; we don't replace it.

  • A leadership change introduces near-term risks to pipeline continuity, deal timing, and expansion motion, just as the company tries to turn product momentum into usage growth

    60% confidence

  • Leadership change introduces near-term risks to pipeline continuity, deal timing, and expansion motion, just as the company tries to turn product momentum into usage growth

    60% confidence

  • Mizuho sees over 40% upside for Snowflake stock with $220 price target

    60% confidence

  • Mizuho sees over 40% upside for Snowflake stock with $220 price target

    60% confidence

  • JB has been a key driver of our success for the past ten years, and has consistently proven his ability to deliver results at scale

    60% confidence

  • Product revenue growth in the second half of FY2026 coming in lighter than expected

    60% confidence

  • JB has been a key driver of Snowflake's success for the past ten years and has consistently proven his ability to deliver results at scale

    60% confidence

  • The next question is whether Q1 results show stable pipeline trends and continued customer expansion under the new CRO

    60% confidence

Data points we hold from this source

Snowflake Inc. · analyst target price239 USD
Snowflake Inc. · enterprise value50 USD
Snowflake Inc. · forward pe ratio84.3 ratio
Snowflake Inc. · implied upside55 percent
O que sabemos · a inteligência por trás desta página
Ao vivo do substrato
O que estamos a ver
Obesity and Immunology Readouts, Big Pharma M&A and AI-Designed Drugs Converge Into a Q4 2026 Catalyst Wave
Late-stage data and deal activity are clustering ahead of Q4 2026. Novo Nordisk's CagriSema won Best Abstract at EASD 2026 for its brain and body (fMRI/MRI) data, Lilly showed ADtouch results for EBGLYSS and agreed to buy Merida Biosciences for $2.9B, and Merck's tulisokibart hit its Phase 2b endpoints. A key regulatory catalyst follows: the FDA PDUFA date for the ivonescimab BLA on 2026-11-14. AI-designed rentosertib showing anti-aging effects adds a speculative AI-drug-discovery thread, while QAIAx's microcities trial and QIII pilot (planned 2027-01-01) are peripheral, forecast-only items.
A nossa leitura dos dados ›
Sinais que acompanhamos
Satellite-Terrestrial Network Integration Acceleration
Increased investment and launches in hybrid satellite-cellular networks across telecom industry; competitive responses from other carriers; regulatory activity around satellite spectrum; expansion of emergency/rural connectivity use cases
Padrões que observamos ›
Onde as fontes divergem
ING Group
Both facts record the same metric (shares_outstanding) for ING Group at the identical observation date (2025-12-31). FACT A states 2,902,437,688 shares; FACT B states 2,902 million shares (2,902,000,000). The difference is 437,688 shares (~0.015%). This is a genuine value conflict, though the discrepancy appears to result from FACT B rounding to the nearest million while FACT A provides the precise count.
Sinalizamos conflitos abertamente ›
Verificado recentemente
✓ Verificado com a fonte original
4,985
factos rastreados à sua fonte — e sinalizamos os que não se confirmam.
101 entidades acompanhadas4,985 factos verificados com a fonte5,351 documentos-fonte arquivados
Consulte estes dados → isubstrate.com
Mizuho resets view on Snowflake stock after CRO change — Source | Via News | pt.VIA.NEWS